Yellow Fever Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

Yellow Fever Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

  • October 2019 •
  • 60 pages •
  • Report ID: 5823559 •
  • Format: PDF
Yellow Fever Drug pipeline report- 2020 is an annual R&D review of Yellow Fever pipeline candidates. The report presents the current status of all major Yellow Fever therapeutic compounds. Detailed insights into Yellow Fever pipeline development, current status, companies, drug profiles and Yellow Fever preclinical and clinical trials are included.

2020 Yellow Fever Pipeline Market Insights
Yellow Fever disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of Yellow Fever therapies, pipeline by phase and others are included.

Yellow Fever pipeline Drug profiles-
Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.

Yellow Fever Therapeutic Drug candidates
Both active and inactive Yellow Fever pipeline drug candidates are included in the report

Yellow Fever Clinical Trials and preclinical Studies
Yellow Fever In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.

Yellow Fever pipeline market developments
Yellow Fever Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.

Yellow Fever pipeline companies in active development

The report analyzes Yellow Fever pipeline of the below companies-
BioCryst Pharmaceuticals Inc, Emergex Vaccines Ltd, Ennaid Therapeutics LLC, Fab’entech SA, GE Healthcare Life Sciences, Heat Biologics Inc, iBio Inc, KinoPharma Inc, Najit Technologies, Tychan Pte Ltd

Report Coverage
- What to look out for in 2020
Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included

- Pipeline Snapshot
Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others

- Companies
10 Companies investing in Yellow Fever pipeline from discovery stage to pre-registration phase are included

- Drug profiles
Over 10 details of each Yellow Fever pipeline candidate are included

- Company Profiles
Business overview and contact details of all companies operating in the industry are provided

- Market Developments
News, Developments and other recent industry developments are included